Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Pacific Biosciences of California, Inc. beats earnings expectations.
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$154.0m ...
PacBio outlines 2025 revenue guidance of $155M-$170M amid new product launches
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Management View CEO Christian Henry highlighted Q4 2024 revenue of $39.2 million, driven by the shipment of 23 Revio systems and the early ...
Pacific Biosciences: Q4 Earnings Snapshot
MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported fourth-quarter profit of $3.6 million. The Menlo Park, California-based company ...
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect
Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus ...
PacBio should return to growth over time, says Canaccord
Canaccord reiterates a Buy rating on PacBio (PACB) with a $3 price target following the company’s Q4 report. The firm says that although PacBio ...
Barclays Keeps Their Hold Rating on Pacific Biosciences (PACB)
In a report released today, Luke Sergott from Barclays maintained a Hold rating on Pacific Biosciences (PACB – Research Report), with a price ...
Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript
Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...